Federal Circuit affirms unpatentability of Janssen patent

25-01-2018

Federal Circuit affirms unpatentability of Janssen patent

berezko / iStockphoto.com

The US Court of Appeals for the Federal Circuit has upheld a finding that a patent which was initially applied for in 1993 is unpatentable, under double patenting rules.


patent rejection, patent obviousness, patent trial and appeal board, ex parte re-examination, US patent validity, double patenting, Remicade

LSIPR